FROPOFOL PREVENTS DISEASE PROGRESSION IN HYPERTROPHIC CARDIOMYOPATHY

Yiyuan Huang,Haisong Lu,Fazhao Li,Wenjie Liu,Xianfeng Ren,Weiming Bu,Kellie A. Woll,Leslie A. Leinwand,Roselle Abraham,Roderic Eckenhoff,Wei Dong Gao

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2018）

引用 13|浏览12

暂无评分

摘要

Increased contractility by the myofilaments themselves is recognized as a crucial factor in the pathogenesis of hypertrophic cardiomyopathy (HCM). In this study, we test the hypothesis that fropofol (a propofol derivative with no anesthetic activity), is a direct myofilament depressing agent that

查看译文

关键词

disease

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要